Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis

BACKGROUND: Brain metastases (BM) from non-small-cell lung cancer (NSCLC) is the most common brain malignancy. Systemic inflammation biomarkers have recently been evaluated as prognosis indicators in several tumors. The combination of these markers has not been evaluated in NSCLC with BM yet. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Chen, Limin, Wang, Zhao, Xu, Qiuyan, Huang, He, Wang, Hairong, Li, Xi, Yu, Mingjie, Chen, Jiangen, Lin, Fuhua, Chen, Zhenghe, Zhang, Xiangheng, Yang, Qunying, Mou, Yonggao, Guo, Chengcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563131/
https://www.ncbi.nlm.nih.gov/pubmed/36242047
http://dx.doi.org/10.1186/s12935-022-02704-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563131/
https://www.ncbi.nlm.nih.gov/pubmed/36242047
http://dx.doi.org/10.1186/s12935-022-02704-w

Ejemplares similares